EUVIMEDEUVIMED entdecken
Crossref

Gut-Brain Axis in Obesity: The Role of Gastrointestinal Hormones and Microbiota in Metabolic Regulation

Nitesh Mishra

International Journal of Current Pharmaceutical Review and Research · 31.03.2026 · 18 (03)

DOI: 10.25258/ijcpr.18.3.273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.03.2026. Verfasst von Nitesh Mishra.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity is a major global health problem associated with metabolic, cardiovascular, and endocrine disorders. Recent evidence has highlighted the role of the gut–brain axis, gastrointestinal hormones, and gut microbiota in regulating appetite, satiety, glucose metabolism, and body weight.

Aim

The present study was conducted to evaluate the role of the gut–brain axis in obesity, with particular emphasis on gastrointestinal hormones and gut microbiota in metabolic regulation.

Methods

This hospital-based observational cross-sectional study included 90 participants, comprising 45 obese individuals and 45 age- and sex-matched non-obese controls. Demographic, anthropometric, clinical, biochemical, hormonal, and gut microbiota parameters were assessed. Serum leptin, ghrelin, glucagon-like peptide-1, peptide YY, insulin, and inflammatory markers were measured. Stool microbiota analysis was performed using 16S rRNA sequencing. Statistical analysis was carried out using independent t-test, Mann– Whitney U test, Chi-square test, and Spearman’s correlation.

Results

Obese participants had significantly higher body mass index, waist circumference, blood pressure, fasting blood glucose, HbA1c, insulin, HOMA-IR, total cholesterol, triglycerides, LDL cholesterol, leptin, and hs-CRP levels compared to non-obese controls (p < 0.001). In contrast, HDL cholesterol, ghrelin, glucagon-like peptide-1, peptide YY, Bacteroidetes abundance, Actinobacteria abundance, and microbial diversity index were significantly lower among obese participants (p < 0.001). Firmicutes abundance, Firmicutes/Bacteroidetes ratio, and Proteobacteria abundance were significantly higher in the obese group. BMI showed positive correlations with leptin, HOMA-IR, and Firmicutes/Bacteroidetes ratio, whereas negative correlations were observed with ghrelin, glucagon-like peptide-1, peptide YY, and microbial diversity index.

Conclusion

The present study demonstrated that obesity was associated with significant dysregulation of gastrointestinal hormones and gut microbiota, suggesting an important role of the gut–brain axis in obesityrelated metabolic dysfunction

Zitieren

APA

Mishra, N. (2026). Gut-Brain Axis in Obesity: The Role of Gastrointestinal Hormones and Microbiota in Metabolic Regulation. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.273

Vancouver

Mishra N. Gut-Brain Axis in Obesity: The Role of Gastrointestinal Hormones and Microbiota in Metabolic Regulation. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.273

BibTeX
@article{Mishra2026,
  author = {Mishra, Nitesh},
  title = {Gut-Brain Axis in Obesity: The Role of Gastrointestinal Hormones and Microbiota in Metabolic Regulation},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {03},
  doi = {10.25258/ijcpr.18.3.273}
}
Kostenlos starten →